Traws Pharma (TRAW) Current Deferred Revenue (2012 - 2025)
Traws Pharma (TRAW) posted quarterly Current Deferred Revenue of $226000.0 for Q1 2025, little changed year-over-year from $226000.0 in Q1 2024, and little changed quarter-over-quarter from $226000.0 in Q4 2024.
Traws Pharma (TRAW) Current Deferred Revenue (2012 - 2025) Analysis & Trends
Traws Pharma (TRAW) has reported Current Deferred Revenue for 14 consecutive years, with $226000.0 the latest figure, recorded in Q1 2025.
- In Q1 2025, Current Deferred Revenue changed 0.0% year-over-year to $226000.0; the TTM figure through Mar 2025 stood at $226000.0 (changed 0.0% YoY), while the FY2024 annual figure was $226000.0, changed 0.0% from the prior year.
- Current Deferred Revenue steadied at $226000.0 in Q1 2025 per TRAW's latest filing, from $226000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $227000.0 in Q2 2024 and bottomed at $226000.0 in Q1 2021.
- Historically, Current Deferred Revenue has averaged $226058.8 across 5 years, with a median of $226000.0 in 2021.
- Annual changes were most pronounced in 2021 — Current Deferred Revenue changed 0.0% — and 2024, when it rose 0.44%.
- Traws Pharma's Current Deferred Revenue stood at $226000.0 in 2021, then changed by 0.0% to $226000.0 in 2022, then changed by 0.0% to $226000.0 in 2023, then changed by 0.0% to $226000.0 in 2024, then changed by 0.0% to $226000.0 in 2025.
- Business Quant data shows TRAW's Current Deferred Revenue at $226000.0 in Q1 2025, $226000.0 in Q4 2024, and $226000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Traws Pharma | 5.66 Mn | 639,491.99 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 226,000.00 |
| Dec 31, 2024 | 226,000.00 |
| Sep 30, 2024 | 226,000.00 |
| Jun 30, 2024 | 227,000.00 |
| Mar 31, 2024 | 226,000.00 |
| Dec 31, 2023 | 226,000.00 |
| Sep 30, 2023 | 226,000.00 |
| Jun 30, 2023 | 226,000.00 |
| Mar 31, 2023 | 226,000.00 |
| Dec 31, 2022 | 226,000.00 |
| Sep 30, 2022 | 226,000.00 |
| Jun 30, 2022 | 226,000.00 |
| Mar 31, 2022 | 226,000.00 |
| Dec 31, 2021 | 226,000.00 |
| Sep 30, 2021 | 226,000.00 |
| Jun 30, 2021 | 226,000.00 |
| Mar 31, 2021 | 226,000.00 |
| Dec 31, 2020 | 226,000.00 |
| Sep 30, 2020 | 226,000.00 |
| Jun 30, 2020 | 226,000.00 |